Carola Ries

This inventor holds 21 USPTO granted patents and 13 published patent applications, plus 3 CIPO patents and 9 EPO patents, primarily in Cancer Immunotherapy. Top assignees: Hoffmann-La Roche Inc., Other. Active years: 2015-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carola Ries. Retrieved from https://idiyas.com/inventor/carola-ries

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 13)

% Patents Active = 61.9

CIPO Patents = 3 (Patent Applications = 6)

EPO Patents = 9 (Patent Applications = 13)

Average Co-Inventor Count = 6.4

ph-index = 10

Forward Citations = 189(Granted Patents)

Company Filing History:

20 out of 5,026

Hoffmann-La Roche Inc.

patents

1 out of 834,513

Other

patents

Years Active: 2015-2023

Loading Chart...

Areas of Expertise:

CSF-1R Antibodies

PD-L1 Antibodies

Tumor Treatment

Cancer Therapy

Nucleic Acids

Cell Proliferation

Combination Therapy

Immunotherapy

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11542335 - Method of treating cancer in a patient by administering an antibody which binds colony stimulating factor-1 receptor (CSF-1R) (2023-01-03),

2. 11512133 - Methods for treating colon cancer or inhibiting cell proliferation by administering a combination of antibodies against human CSF-1R and antibodies against human PD-L1 (2022-11-29),

3. 11498968 - Treatment of tumors with an anti-CSF-1R antibody in combination with an anti-PD-L1 antibody after failure of anti-PD-L1/PD1 treatment (2022-11-15),

4. 10336830 - Antibodies against human CSF-1R and uses thereof (2019-07-02),

5. 10287358 - Antibodies against human CSF-1R and uses thereof (2019-05-14),

6. 10077314 - Antibodies against human CSF-1R and uses thereof (2018-09-18),

7. 10072087 - Antibodies against human CSF-1R and uses thereof (2018-09-11),

8. 10030073 - Antibodies against human CSF-1R and uses thereof (2018-07-24),

9. 10023643 - Antibodies against human CSF-1R and uses thereof (2018-07-17),

10. 9988458 - Antibodies against human CSF-1R and uses thereof (2018-06-05),

11. 9879085 - Antibodies against human CSF-1R and uses thereof (2018-01-30),

12. 9663580 - Antibodies against human CSF-1R and uses thereof (2017-05-30),

13. 9624302 - Nucleic acids encoding antibodies against human CSF-1R (2017-04-18),

14. 9617342 - Nucleic acids encoding antibodies against human CSF-1R and uses thereof (2017-04-11),

15. 9499626 - Antibodies against human CSF-1R and uses thereof (2016-11-22),

Title: The Innovative Journey of Carola Ries

Introduction: Carola Ries is a pioneering inventor hailing from Penzberg, Germany, known for her groundbreaking contributions to various fields.

Latest Patents: Carola Ries holds several patents in the areas of renewable energy technologies, sustainable materials, and medical devices, showcasing her diverse range of expertise.

Career Highlights: With a career spanning over two decades, Carola Ries has worked with leading research institutions and companies to develop cutting-edge solutions that have had a significant impact on society.

Collaborations: Throughout her career, Carola Ries has collaborated with top universities, research institutions, and innovative companies to bring her inventions to life and drive forward progress in the industry.

Conclusion: Carola Ries continues to be a driving force in the world of innovation, with her passion for creating impactful solutions that push the boundaries of what is possible.

Profile summary based on public USPTO records.